2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan
7.5.2026 15:00:00 EEST | Business Wire | Press release
Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/
2M+ Downloads in 6 Months.
The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors.
Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r
The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan
For years, international visitors to Japan have faced two critical dining pain points:
[Pain Point 1] The Information Gap: Most available resources are tailored for tourists, making it difficult to find the true local favorites where locals actually dine.
[Pain Point 2] The Language Barrier: Since many restaurants only accept phone reservations in Japanese, travelers are often forced to miss out on the restaurants at the top of their list.
The Tabelog multilingual app provides a fundamental solution to these two pain points.
Leveraging an extensive database of genuine reviews and photos from local diners in Japan, the app is highly regarded for its ability to guide travelers to true local favorites.
By facilitating instant reservations in English, Traditional Chinese, and Korean, Tabelog fulfills the essential traveler desire to “Eat Where Locals Eat,” delivering a seamless and stress-free dining experience.
Superior Reliability Built on Japan’s Largest Dining Dataset
● Approx. 890,000 restaurant listings (Comprehensive nationwide coverage)
● Over 90 million reviews (Contributed by local diners in Japan)
● Over 200 million photos (Authentic shots of food and interiors)
● Over 70,000 restaurants available for instant online booking (*4) — from major cities like Tokyo, Osaka, and Kyoto to regional areas
This vast database serves as the definitive benchmark for travelers to discover "truly exceptional dining" across Japan.
Main App Features
1. Discover Gems Rated by Local Diners
Leveraging the honest ratings of local diners in Japan, the app helps travelers look beyond typical tourist recommendations. It fulfills the desire to experience the same quality and atmosphere that the local community enjoys every day.
2. Seamless Instant Reservations via Mobile: Overcoming the Language Barrier (*4)
By removing the requirement for phone conversations, the app empowers travelers to book in their preferred language. Reservations are completed in seconds with instant confirmation, giving users the freedom to explore Japan’s dining scene without the anxiety of language barriers.
3. Abundant Choices Across Japan: From Metropolitan Hubs to Regional Gems
Travelers gain access to the full spectrum of Japan’s culinary landscape, from world-renowned establishments in metropolitan hubs to hidden gems tucked away in regional areas. With over 70,000 restaurants available for instant online booking (*5), the platform’s reach extends far beyond traditional tourist centers to every corner of the country.
4. Intuitive UX Tailored for Global Travelers
The app integrates features designed for maximum convenience, such as "Save Lists" and sorting by "Most Reserved by Locals." By streamlining the discovery process, Tabelog delivers an intuitive, friction-free experience that enables travelers to find the perfect restaurant with ease, even while on the go.
Looking Ahead: Empowering Local Economies and Advancing Sustainable Tourism
Tabelog is dedicated to fostering a world where international travelers can fully immerse themselves in Japan’s exceptional dining culture, completely free from language barriers.
By bridging the gap between global explorers and diverse restaurants across the nation, we aim to inspire journeys into undiscovered regional gems. This initiative promotes a more sustainable form of tourism—one that directs vital support to local businesses and communities far beyond traditional tourist hubs.
Tabelog remains committed to enhancing its features and expanding its reach, ensuring that travelers can seamlessly connect with Japan's most authentic culinary gems, nationwide.
(*1) | Restaurant search and reservation site with the most listed establishments survey (May 2024/internal research). Accessed target sites (Tabelog, Hot Pepper Gourmet, Gurunavi, Retty, Hitosara) and tallied all listed establishments displayed in searches without filtering, by prefecture. |
(*2) | As of April 30, 2026. |
(*3) | November 2025/AppTweak research. Combined downloads from "Food & Drink (Restaurants & Cafes)" and "Travel & Navigation (Trip Planner)" categories on App Store and Google Play in surveyed regions (Taiwan, Hong Kong, South Korea, United States). Compared as Japanese Restaurant Search Apps. Source: AppTweak (https://www.apptweak.com) |
(*4) | A standard system usage fee applies to each confirmed reservation. |
(*5) | As of May 7, 2026. |
About Kakaku.com, Inc.
Founded in 1997, Kakaku.com has been operating since the early days of Japan's internet era. Currently, the company plans and operates various web services deeply rooted in daily life, including the purchasing support site "Kakaku.com," restaurant search and reservation service "Tabelog," and job search aggregation service "Kyujin Box." Listed on the Tokyo Stock Exchange Prime Market (Securities Code: 2371), the company provides platforms with the largest user bases in Japan across multiple sectors.
Service Overview: https://corporate.kakaku.com/en/service
View source version on businesswire.com: https://www.businesswire.com/news/home/20260507560248/en/
Contacts
Kakaku.com, Inc.
Public Relations and Investor Relations Office
pr@kakaku.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura ® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 15:50:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs). These data were presented (Abstract ID: P0851) today at the 2026 European Academy of Dermatology and Venereology (EADV) Symposium, being held May 7–9, 2026, in Athens, Greece. As previously reported, the TRuE-AD4 study met both of its co-primary endpoints at Week 8, with a statistically significantly higher proportion of patients on Opzelura versus vehicle cream achieving EASI75 (≥75% improvement in Eczema Area and Severity Index score from baseline) and, separately, IGA-TS (Investigator's Global Assessment Treatment Success, defined as an IGA score of 0 [clear] or 1 [almost clear] with at least a two-point improvement from baseline).1 Patients who
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 15:03:00 EEST | Press release
Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L. Saver, MD, UCLA, and Principal Investigator of DISTALS. “What’s important is that both the device and the trial were designed specifically for distal stroke. By using a device built for these small vessels and mea
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 15:00:00 EEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 14:00:00 EEST | Press release
In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football trading cards from 2031 onward. All products will be designed and developed through Fanatics Collectibles and produced under the Topps brand. As a part of the deal, Fanatics will bring the magic to young people in every region of the world and support youth football globally by distributing more than $150 million in collect
DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved7.5.2026 12:21:00 EEST | Press release
The DEFINITIVE project, a landmark European Union-funded international phase III clinical trial evaluating the use of the HER2DX diagnostic assay to guide personalised treatment in early-stage HER2-positive breast cancer (BC), announces two major operational milestones at the ESMO Breast Cancer 2026 congress. Approvals have been obtained in the 7 participating countries, 33 clinicals sites are now open for patient recruitment. The trial has reached over 50% of its recruitment target, marking a pivotal moment on the path toward to transforming HER2-positive BC treatment. About the DEFINITIVE Project The DEFINITIVE project is a 5-year, prospective, open-label, randomised, two-arm phase III international clinical trial conducted across 44 centres in 7 European member states and associated countries. The trial aims to demonstrate that personalising treatment decisions for patients with early-stage (stage II to IIIA) HER2-positive BC using the HER2DX genomic diagnostic assay can improve pat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom